Morgan Health announced Monday that it has hired Dr. Cheryl Pegus to support the organization’s “strategic investments and broader efforts to improve the quality, affordability and equity of healthcare.”

Pegus, who most recently served as EVP of health and wellness at Walmart, will work alongside Dan Hartman and Jeff Ries, two executives who lead Morgan Health’s ventures and investment efforts. So far, Morgan Health has deployed $105 million worth of the $250 million in JPMorgan Chase’s capital set aside for supporting companies that drive greater accountability in healthcare. 

While at Walmart, Pegus bolstered the retail giant’s foothold in the healthcare industry by broadening access to its telehealth capabilities, expanding its health centers across major markets and launching several consumer health programs, including the rollout of ReliOn insulin. She will also continue to serve as a senior advisor to Walmart. 

“Healthcare innovation continues to be very much needed, and I am excited to support this incredible Morgan Health team in accelerating offerings that improve outcomes,” Pegus said in a statement. “Moving new science into practice, supporting consumers in understanding what’s available and needed to stay healthy, while assisting healthcare professionals in doing our best work can deliver on the Quadruple Aim.” 

A company press release stated that Pegus will be tasked with building upon Morgan Health’s accountable care strategy foundation and scale new delivery models to improve outcomes, especially among marginalized patient populations.

Prior to her stint at Walmart, Pegus served as president of consumer solutions and chief medical officer for Cambia Health Solutions, the first chief medical officer of Walgreens and general manager and chief medical officer for SymCare Personalized Health Solutions, a division of Johnson & Johnson